The revised AAP Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation was released in 2022 after 15 years of development. The guidelines focus on updated treatment thresholds and risk factors to prevent bilirubin encephalopathy and kernicterus. Key changes include higher phototherapy thresholds and risk-adjusted curves based on gestational age. The guidelines introduce the concept of "escalation of care" for medical emergencies and emphasize the importance of early and frequent feeding to reduce the need for phototherapy. Practitioners are encouraged to use tools like Bilitool.org to apply the new guidelines effectively.
To Another Language
from source content
www.medscape.com
Key Insights Distilled From
by Michelle I. ... at www.medscape.com 06-26-2023
https://www.medscape.com/viewarticle/993600Deeper Inquiries